CUDC-907,
CUDC-907,
1339928-25-4,
Fimepinostat,
CUDC 907,
UNII-3S9RX35S5X,
CUDC907,
3S9RX35S5X,
N-hydroxy-2-[[2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl-methylamino]pyrimidine-5-carboxamide,
CHEMBL3622533,
Fimepinostat [USAN],
pi3k-hdac-inhibitor-i,
PI3K/HDAC Inhibitor,
PI3K/HDAC Inhibitor centn,
MLS006010994,
GTPL8952,
SCHEMBL1284705,
KS-00000TDO,
AOB6775,
DTXSID90712307,
EX-A742,
JOWXJLIFIIOYMS-UHFFFAOYSA-N,
HMS3656H04,
BCP06870,
2341AH,
ABP001045,
BDBM50188961,
MFCD22420823,
s2759,
ZINC73488511,
AKOS026750340,
CS-1610,
CUDC-907 (PI3K/HDAC InhibitorI),
DB11891,
SB16569,
NCGC00346692-01,
AC-30227,
AK199731,
BC600514,
HY-13522,
QC-11642,
SMR004702794,
FT-0700168,
SW219871-1,
Z-3251,
J-690133,
1339928-25-4 , C23H24N8O4S , CUDC907 , CUDC 907,
5-pyrimidinecarboxamide, N-hydroxy-2-[[[2-(6-methoxy-3-pyridinyl)-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]methylamino]-,
N-hydroxy-2-(((2-(6-methoxypyridin-3-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)(methyl)amino)pyrimidine-5-carboxamide,
N-Hydroxy-2-[[[2-(6-methoxy-3-pyridinyl)-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]methylamino]-5-pyrimidinecarboxamide,
N-Hydroxy-2-[{[2-(6-methoxypyridin-3-yl)-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}(methyl)amino]pyrimidine-5-carboxamide,
D0E6UZ,
C23H24N8O4S,
CUDC-907, 98% - 5MG 5mg,
A4097,
A11153,
2-((4R)-8-Chloro-6-(4-chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide,
5-?Pyrimidinecarboxamid?e, N-?hydroxy-?2-?[[[2-?(6-?methoxy-?3-?pyridinyl)?-?4-?(4-?morpholinyl)?thieno[3,?2-?d]?pyrimidin-?6-?yl]?methyl]?methylamino]?-,
N-Hydroxy-2-[[[2-(6-methoxypyridin-3-yl)-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl](methyl)amino]pyrimidine-5-carboxamide,